|
1
|
Jabbour EJ, Faderl S and Kantarjian HM:
Adult acute lymphoblastic leukemia. Mayo Clin Proc. 80:1517–1527.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coustan-Smith E, Mullighan CG, Onciu M,
Behm FG, Raimondi SC, Pei D, Cheng C, Su X, Rubnitz JE, Basso G, et
al: Early T-cell precursor leukaemia: A subtype of very high-risk
acute lymphoblastic leukaemia. Lancet Oncol. 10:147–156. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Armstrong SA and Look AT: Molecular
genetics of acute lymphoblastic leukemia. J Clin Oncol.
23:6306–6315. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goldberg JM, Silverman LB, Levy DE, Dalton
VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE and Asselin BL:
Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber
cancer institute acute lymphoblastic leukemia consortium
experience. J Clin Oncol. 21:3616–3622. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: MicroRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yendamuri S and Calin GA: The role of
microRNA in human leukemia: A review. Leukemia. 23:1257–1263. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumar MS, Lu J, Mercer KL, Golub TR and
Jacks T: Impaired microRNA processing enhances cellular
transformation and tumorigenesis. Nat Genet. 39:673–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baraniskin A, Kuhnhenn J, Schlegel U, Chan
A, Deckert M, Gold R, Maghnouj A, Zöllner H, Reinacher-Schick A,
Schmiegel W, et al: Identification of microRNAs in the
cerebrospinal fluid as marker for primary diffuse large B-cell
lymphoma of the central nervous system. Blood. 117:3140–3146. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gu L, Song G, Chen L, Nie Z, He B, Pan Y,
Xu Y, Li R, Gao T, Cho WC and Wang S: Inhibition of miR-21 induces
biological and behavioral alterations in diffuse large B-cell
lymphoma. Acta Haematol. 130:87–94. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu C, Yu J, Yu S, Lavker RM, Cai L, Liu
W, Yang K, He X and Chen S: MicroRNA-21 acts as an oncomir through
multiple targets in human hepatocellular carcinoma. J Hepatol.
53:98–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu R, Jiang Y, Wu Q, Li Q, Cheng D, Xu L,
Zhang C, Zhang M and Ye L: Diagnostic value of microRNA-21 in the
diagnosis of lung cancer: Evidence from a meta-analysis involving
11 studies. Tumour Biol. 35:8829–8836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S and
Navab R: MicroRNA-21 (miR-21) regulates cellular proliferation,
invasion, migration, and apoptosis by targeting PTEN, RECK and
Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One.
9:e1036982014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu MF, Yang J, Xiang T, Shi YY and Liu LJ:
miR-21 targets Fas ligand-mediated apoptosis in breast cancer cell
line MCF-7. J Huazhong Univ Sci Technolog Med Sci. 34:190–194.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Frank DA: STAT3 as a central mediator of
neoplastic cellular transformation. Cancer Lett. 251:199–210. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Löffler D, Brocke-Heidrich K, Pfeifer G,
Stocsits C, Hackermüller J, Kretzschmar AK, Burger R, Gramatzki M,
Blumert C, Bauer K, et al: Interleukin-6 dependent survival of
multiple myeloma cells involves the Stat3-mediated induction of
microRNA-21 through a highly conserved enhancer. Blood.
110:1330–1333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van der Fits L, van Kester MS, Qin Y,
Out-Luiting JJ, Smit F, Zoutman WH, Willemze R, Tensen CP and
Vermeer MH: MicroRNA-21 expression in CD4+ T cells is regulated by
STAT3 and is pathologically involved in Sezary syndrome. J Invest
Dermatol. 131:762–768. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fujita S, Ito T, Mizutani T, Minoguchi S,
Yamamichi N, Sakurai K and Iba H: miR-21 gene expression triggered
by AP-1 is sustained through a double-negative feedback mechanism.
J Mol Biol. 378:492–504. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ou H, Li Y and Kang M: Activation of
miR-21 by STAT3 Induces Proliferation and Suppresses apoptosis in
nasopharyngeal carcinoma by targeting PTEN gene. PLoS One.
9:e1099292014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sontheimer EJ: Assembly and function of
RNA silencing complexes. Nat Rev Mol Cell Biol. 6:127–138. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bourguignon LY, Earle C, Wong G, Spevak CC
and Krueger K: Stem cell marker (Nanog) and Stat-3 signaling
promote MicroRNA-21 expression and chemoresistance in
hyaluronan/CD44-activated head and neck squamous cell carcinoma
cells. Oncogene. 31:149–160. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kohanbash G and Okada H: MicroRNAs and
STAT interplay. Semin Cancer Biol. 22:70–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carraro G, El-Hashash A, Guidolin D,
Tiozzo C, Turcatel G, Young BM, De Langhe SP, Bellusci S, Shi W,
Parnigotto PP and Warburton D: miR-17 family of microRNAs controls
FGF10-mediated embryonic lung epithelial branching morphogenesis
through MAPK14 and STAT3 regulation of E-Cadherin distribution. Dev
Biol. 333:238–250. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao Q, Li YY, He WF, Zhang ZZ, Zhou Q, Liu
X, Shen Y and Huang TT: Interplay between microRNAs and the STAT3
signaling pathway in human cancers. Physiol Genomics. 45:1206–1214.
2013. View Article : Google Scholar : PubMed/NCBI
|
